The massive ongoing Ebola outbreak in the Democratic Republic of the Congo, driven by the Bundibugyo strain and declared in May 2026, dominates trader sentiment for countries reporting cases this year. With over 5,800 confirmed cases and nearly 3,000 deaths across multiple provinces by late August, the DRC's rapid spread amid insecurity, population displacement, and mobility has made it the clear frontrunner. Imported cases reached Uganda (outbreak now declared over after 20 total) and France (one confirmed), while response efforts including Ervebo vaccination rollout and contact tracing improvements signal potential containment. Uncertainty lingers around further cross-border transmission before year-end given weak surveillance and community challenges.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$37,836 Vol.
Dec 31, 2026
South Sudan
61%
Rwanda
24%
Burundi
52%
United States
21%
Canada
24%
Kenya
24%
India
44%
Republic of the Congo
30%
Nigeria
48%
Ethiopia
55%
Somalia
35%
China
16%
$37,836 Vol.
South Sudan
$3,740 Vol.
61%
Rwanda
$2,149 Vol.
24%
Burundi
$202 Vol.
52%
United States
$10,507 Vol.
21%
Canada
$2,273 Vol.
24%
Kenya
$235 Vol.
24%
India
$737 Vol.
44%
Republic of the Congo
$12,299 Vol.
30%
Nigeria
$25 Vol.
48%
Ethiopia
$107 Vol.
55%
Somalia
$71 Vol.
35%
China
$3,537 Vol.
16%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The massive ongoing Ebola outbreak in the Democratic Republic of the Congo, driven by the Bundibugyo strain and declared in May 2026, dominates trader sentiment for countries reporting cases this year. With over 5,800 confirmed cases and nearly 3,000 deaths across multiple provinces by late August, the DRC's rapid spread amid insecurity, population displacement, and mobility has made it the clear frontrunner. Imported cases reached Uganda (outbreak now declared over after 20 total) and France (one confirmed), while response efforts including Ervebo vaccination rollout and contact tracing improvements signal potential containment. Uncertainty lingers around further cross-border transmission before year-end given weak surveillance and community challenges.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Market Opened: May 22, 2026, 12:35 PM ET
Volume
$37,836End Date
Jan 1, 2027Market Opened
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The massive ongoing Ebola outbreak in the Democratic Republic of the Congo, driven by the Bundibugyo strain and declared in May 2026, dominates trader sentiment for countries reporting cases this year. With over 5,800 confirmed cases and nearly 3,000 deaths across multiple provinces by late August, the DRC's rapid spread amid insecurity, population displacement, and mobility has made it the clear frontrunner. Imported cases reached Uganda (outbreak now declared over after 20 total) and France (one confirmed), while response efforts including Ervebo vaccination rollout and contact tracing improvements signal potential containment. Uncertainty lingers around further cross-border transmission before year-end given weak surveillance and community challenges.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$37,836End Date
Jan 1, 2027Market Opened
May 22, 2026, 12:35 PM ETResolver
0x65070BE91...The massive ongoing Ebola outbreak in the Democratic Republic of the Congo, driven by the Bundibugyo strain and declared in May 2026, dominates trader sentiment for countries reporting cases this year. With over 5,800 confirmed cases and nearly 3,000 deaths across multiple provinces by late August, the DRC's rapid spread amid insecurity, population displacement, and mobility has made it the clear frontrunner. Imported cases reached Uganda (outbreak now declared over after 20 total) and France (one confirmed), while response efforts including Ervebo vaccination rollout and contact tracing improvements signal potential containment. Uncertainty lingers around further cross-border transmission before year-end given weak surveillance and community challenges.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions